EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Transcatheter Edge-to-Edge Repair in Patients With Primary Tricuspid Regurgitation

Atsushi Sugiura, Julien Dreyfus, Sara Bombace, Maria Ivannikova, Joanna Bartkowiak, Stephan Haussig, Leonhard Moritz Schneider, Mohammad Kassar, Patrick Horn, Maurizio Taramasso, Christos Iliadis, Itsuki Osawa und 30 weitere

JACC: Cardiovascular Interventions · 2025

DOI: 10.1016/j.jcin.2025.03.023 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2025. Verfasst von Atsushi Sugiura und 41 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II, University Hospital Bonn, Bonn, Germany. Electronic address: atsushi.sugiura@ukbonn.de. Hauptthemen laut MEDLINE: Tricuspid Valve Insufficiency, Cardiac Catheterization, Heart Valve Prosthesis Implantation, Tricuspid Valve. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Edwards Lifesciences Corp.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Tricuspid regurgitation (TR) leads to right heart congestion and increased mortality risk. Unlike secondary TR, primary TR results from leaflet degeneration. Transcatheter edge-to-edge repair (TEER) is widely used for TR. However, its feasibility primary TR remains uncertain. OBJECTIVES: The aim of this study was to assess the safety and feasibility of TEER in patients with primary TR. METHODS: The primary TR registry is a multicenter cohort study of patients with primary TR undergoing TEER. Echocardiographic assessment classified leaflet pathology into type 1 (flail), type 2 (billowing prolapse), type 3 (perforation), and type 4 (restricted mobility). The primary endpoint was TR reduction to moderate or less at discharge. RESULTS: From December 2016 to April 2023, 114 patients (mean age 79.9 years, 53.5% men) were included. Most patients were in NYHA functional class III or IV (83.3%), with a median TRI-SCORE of 5.0. The TR pathologies were type 1 (28.1%), type 2 (61.4%), and type 4 (10.5%), with no type 3 cases. Device deployment was achieved in 95.6%, and 83.3% showed TR reduction to moderate or less. In-hospital mortality was 1.8%, and single-leaflet device attachment occurred in 3.5%. At 1 year, 79.7% of patients had TR moderate or less, with significant reductions in vena contracta (-5.0 mm; P < 0.001), annular diameter (-2.0 mm; P = 0.003), and mid right ventricular diameter (-3.0 mm; P < 0.001). NYHA functional class also improved significantly (NYHA functional class I or II: 17.1% at baseline vs 66.5% at follow-up; P < 0.001). CONCLUSIONS: TEER is a safe and effective option for primary TR, promoting right heart reverse remodeling and symptomatic relief, offering a vital alternative to surgery in selected patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tricuspid Valve InsufficiencyCardiac CatheterizationHeart Valve Prosthesis ImplantationTricuspid ValveHumansMaleFemaleAgedTreatment OutcomeRegistriesAged, 80 and overTime FactorsFeasibility StudiesRecovery of FunctionRisk FactorsHemodynamicsRetrospective Studies

Stichwörter der Autor:innen

primary tricuspid regurgitationsurgerytranscatheter edge-to-edge repairtricuspid regurgitation

Autor:innen und Institutionen

  • Department of Internal Medicine II, University Hospital Bonn, Bonn, Germany. Electronic address: atsushi.sugiura@ukbonn.de.
  • Department of Cardiology, Centre Cardiologique du Nord, Saint-Denis, France.
  • Department of Cardiology, University Medical Center of Johannes Gutenberg University Mainz, Mainz, Germany.
  • General and Interventional Cardiology, Heart and Diabetes Center NRW, University Hospital of the Ruhr University Bochum, Bad Oeynhausen, Germany.
  • Cardiology Department, NewYork-Presbyterian/Columbia University Medical Center, New York, New York, USA.
  • Department for Cardiology, University Heart Center Dresden, Dresden, Germany.

Förderung

  • Edwards Lifesciences Corp

Zitieren

APA

Sugiura, A., Dreyfus, J., Bombace, S., Ivannikova, M., Bartkowiak, J., Haussig, S., Schneider, L. M., Kassar, M., Horn, P., Taramasso, M., Iliadis, C., Osawa, I., Goto, T., Weber, M., Tanaka, T., Zimmer, S., Obadia, J. F., Habib, G., Bazire, B., …, & Nickenig, G. (2025). Transcatheter Edge-to-Edge Repair in Patients With Primary Tricuspid Regurgitation. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2025.03.023

Vancouver

Sugiura A, Dreyfus J, Bombace S, Ivannikova M, Bartkowiak J, Haussig S, et al. Transcatheter Edge-to-Edge Repair in Patients With Primary Tricuspid Regurgitation. JACC: Cardiovascular Interventions. 2025. doi:10.1016/j.jcin.2025.03.023

BibTeX
@article{Sugiura2025,
  author = {Sugiura, Atsushi and Dreyfus, Julien and Bombace, Sara and Ivannikova, Maria and Bartkowiak, Joanna and Haussig, Stephan and Schneider, Leonhard Moritz and Kassar, Mohammad and Horn, Patrick and Taramasso, Maurizio and Iliadis, Christos and Osawa, Itsuki and Goto, Tadahiro and Weber, Marcel and Tanaka, Tetsu and Zimmer, Sebastian and Obadia, Jean-François and Habib, Gilbert and Bazire, Baptiste and Iung, Bernard and Bohbot, Yohan and Tribouilloy, Christophe and Donal, Erwan and Nejjari, Mohammed and Riant, Elisabeth and Le Tourneau, Thierry and Lavie-Badie, Yoan and Coisne, Augustin and Modine, Thomas and Lim, Pascal and Doguet, Fabien and Selton-Suty, Christine and Baldus, Stephan and Kelm, Malte and Praz, Fabien and Rottbauer, Wolfgang and Hans-Peter Linke, Axel and Hahn, Rebecca and Volker, Rudolph and Messika-Zeitoun, David and Lurz, Philip and Nickenig, Georg},
  title = {Transcatheter Edge-to-Edge Repair in Patients With Primary Tricuspid Regurgitation},
  journal = {JACC: Cardiovascular Interventions},
  year = {2025},
  doi = {10.1016/j.jcin.2025.03.023}
}
Kostenlos starten →